Cleveland-Cliffs Inc.
13.90USD
+0.8500 (+6.51%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CLF.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.42▲ | $0.17 | 2 | 0 |
| Next quarter | $0.46▲ | $0.27 | 1 | 1 |
| Current year | $0.06▲ | -$0.28 | 1 | 0 |
| Next year | $1.46▲ | $0.36 | 1 | 0 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-09-30 | $0.23 | $0.28 | +0.05 (+19.9%) |
| 2026-06-30 | -$0.22 | -$0.2 | +0.02 (+7.2%) |
| 2026-03-31 | -$0.42 | -$0.4 | +0.02 (+3.8%) |
| 2025-12-31 | -$0.62 | -$0.43 | +0.19 (+30.1%) |
292 ratings from 38 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| B. Riley Securities | Maintained | Buy | $15 $18 | Oct 22, 2026 |
| Barclays | Maintained | Underweight | $11 $12 | Oct 22, 2026 |
| JP Morgan | Maintained | Neutral | $12 $13 | Oct 22, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $12.5 $14 | Oct 20, 2026 |
| Wells Fargo | Maintained | Overweight | $14 $17 | Oct 20, 2026 |
| Barclays | Maintained | Underweight | $10 $11 | Oct 19, 2026 |
| JP Morgan | Maintained | Neutral | $13 $12 | Oct 9, 2026 |
| Wells Fargo | Upgraded from Equal-Weight | Overweight | $12 $14 | Oct 6, 2026 |
| GLJ Research | Maintained | Buy | $15.6 $17.48 | Sep 21, 2026 |
| GLJ Research | Reiterated | Buy | $15.6 | Sep 18, 2026 |
| JP Morgan | Maintained | Neutral | $11 $13 | Sep 9, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $11 $12 | Aug 24, 2026 |
| GLJ Research | Upgraded from Neutral | Buy | $15.01 $15.6 | Jul 24, 2026 |
| Barclays | Maintained | Underweight | $9 $10 | Jul 24, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $9 $11 | Jul 24, 2026 |
| JP Morgan | Maintained | Neutral | $13 $10 | Jul 15, 2026 |
| B of A Securities | Maintained | Neutral | $14 $11.5 | Jul 9, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $14 $9 | Jul 9, 2026 |
| Citigroup | Maintained | Neutral | $11 $10 | Jul 7, 2026 |
| Morgan Stanley | Downgraded from Overweight | Equal-Weight | $12 $12.5 | Jun 22, 2026 |
| JP Morgan | Maintained | Neutral | $9 $13 | Jun 10, 2026 |
| GLJ Research | Upgraded from Sell | Hold | $9.03 $15.01 | Jun 9, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $9 $14 | Jun 4, 2026 |
| Barclays | Initiated | Underweight | $9 | May 22, 2026 |
| Morgan Stanley | Maintained | Overweight | $16.8 $12 | Apr 21, 2026 |
56 filings from 20 insiders · 2 buy / 1 sell over 6m
Officers and directors of CLF, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Camara EdilsonDirector | Buy | 7.4k | $13.49 | $100k | Oct 22, 2026 |
| CRONIN JANE M.Director | Grant | 3.5k | $11.47 | $40k | Oct 1, 2026 |
| Bloom Ron A.Director | Grant | 3.5k | $11.47 | $40k | Oct 1, 2026 |
| CRONIN JANE M.Director | Grant | 4.2k | $9.42 | $40k | Jul 1, 2026 |
| BLOOM RON A.Director | Grant | 4.2k | $9.42 | $40k | Jul 1, 2026 |
| GONCALVES CELSO L. JR.Chief Financial Officer | Sell | 214.3k | $13.41 | $2.87M | Jun 5, 2026 |
| YOCUM ARLENE MDirector | Grant | 15.3k | — | — | Apr 21, 2026 |
| CRONIN JANE M.Director | Grant | 15.3k | — | — | Apr 21, 2026 |
| BLOOM RON A.Director | Grant | 15.3k | — | — | Apr 21, 2026 |
| OREN BENDirector | Grant | 15.3k | — | — | Apr 21, 2026 |
| CAMARA EDILSONDirector | Grant | 15.3k | — | — | Apr 21, 2026 |
| MICHAEL RALPH S IIIDirector | Grant | 15.3k | — | — | Apr 21, 2026 |
| CRONIN JANE M.Director | Grant | 4.5k | $8.27 | $37k | Apr 1, 2026 |
| BLOOM RON A.Director | Grant | 4.8k | $8.27 | $40k | Apr 1, 2026 |
| STOLIAR GABRIELDirector | Grant | 2.4k | $8.27 | $20k | Apr 1, 2026 |
| SMITH CLIFFORD T.Chief Operating Officer | Sell | 200.0k | $10.46 | $2.09M | Feb 17, 2026 |
| CAMARA EDILSONDirector | Buy | 19.7k | $10.13 | $200k | Feb 13, 2026 |
| GONCALVES LOURENCO CELSOChief Executive Officer | Sellindirect | 3.00M | $12.42 | $37.26M | Feb 11, 2026 |
| CRONIN JANE M.Director | Grant | 3.0k | $13.28 | $40k | Jan 2, 2026 |
| BLOOM RON A.Director | Grant | 3.0k | $13.28 | $40k | Jan 2, 2026 |
Analyst Ratings
10 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 2 | 10 | 0 | 1 | Hold3.00 |
| 1 mo ago | 0 | 1 | 11 | 0 | 1 | Hold3.08 |
| 2 mo ago | 0 | 1 | 11 | 0 | 1 | Hold3.08 |
| 3 mo ago | 0 | 1 | 11 | 0 | 1 | Hold3.08 |
Members whose judged calls on CLF have played out most reliably.
No settled calls on CLF yet. 1 call is open, the first due Sep 9, 2027.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice